Skip to main content

Advertisement

ADVERTISEMENT

Volume 15 - Issue 1 - January 2018

Column

Editor's Corner
02/09/2018
The authors evaluated their 1- and 2-year patency rates as well as the clinically driven reintervention rates in their patients with diffuse de novo and instent restenotic FP atherosclerotic lesions greater than 20 cm who received the Zilver...
The authors evaluated their 1- and 2-year patency rates as well as the clinically driven reintervention rates in their patients with diffuse de novo and instent restenotic FP atherosclerotic lesions greater than 20 cm who received the Zilver...
The authors evaluated their 1-...
02/09/2018
Vascular Disease Management
Editor's Corner
01/24/2018
Dr. Walker comments on Poli and colleagues’ article on the implantation of the ACURATE neo transcatheter aortic valve to treat a patient with severe aortic stenosis via a subclavian artery that was surgically exposed.
Dr. Walker comments on Poli and colleagues’ article on the implantation of the ACURATE neo transcatheter aortic valve to treat a patient with severe aortic stenosis via a subclavian artery that was surgically exposed.
Dr. Walker comments on Poli and...
01/24/2018
Vascular Disease Management

Feature

Case Report
02/08/2018
Severe iliofemoral arteriopathies precludes transfemoral access in approximately one-third of patients, but subclavian access represents an alternative option for these patients.
Severe iliofemoral arteriopathies precludes transfemoral access in approximately one-third of patients, but subclavian access represents an alternative option for these patients.
Severe iliofemoral...
02/08/2018
Vascular Disease Management

News

Conference Coverage
01/24/2018
Superficial femoral artery (SFA) is an area of intense research interest and multiple options for treatment. In this Q&A, Gary Ansel, MD, FACC, explains the takeaways from recently released data on various devices and therapies.
Superficial femoral artery (SFA) is an area of intense research interest and multiple options for treatment. In this Q&A, Gary Ansel, MD, FACC, explains the takeaways from recently released data on various devices and therapies.
Superficial femoral artery (SFA)...
01/24/2018
Vascular Disease Management

Advertisement

Advertisement

Advertisement